Literature DB >> 23188789

Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.

Miguel A Materin1, Gregory A Kuzmik, Paul T Jubinsky, Frank J Minja, Jeremy D Asnes, Ketan R Bulsara.   

Abstract

We present a description of retinoblastoma treated with supraselective intra-arterial chemotherapy, demonstrating selective delivery of the infused chemotherapeutic agent into the tumor bed by MRI. A 7-month-old presented with group E (international classification) unilateral retinoblastoma. We treated the patient with several rounds of intra-ophthalmic artery melphalan. Gadolinium was infused along with melphalan to visualize the distribution of this chemotherapeutic drug. Intraoperative MRI was obtained within 15 min after treatment and showed increased enhancement of the tumor and subretinal space. We demonstrate here that supraselective administration of chemotherapy into the ophthalmic artery appears to result in drug delivery to the tumor and subretinal space.

Entities:  

Keywords:  Angiography; MRI; Neoplasm; Pediatrics; Tumor

Mesh:

Substances:

Year:  2012        PMID: 23188789     DOI: 10.1136/neurintsurg-2012-010508.rep

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  2 in total

1.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

2.  Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery.

Authors:  Megan A Rowlands; Ijah Mondesire-Crump; Ariana Levin; Audrey Mauguen; Jasmine H Francis; Ira J Dunkel; Scott E Brodie; Y Pierre Gobin; David H Abramson
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.